PEMVIDUTIDE-INDUCED LIVER FAT REDUCTION IN SUBJECTS WITH NONALCOHOLIC FATTY LIVER DISEASE CORRELATE WITH IMPROVEMENTS IN NONINVASIVE MARKERS OF INFLAMMATION AND FIBROSIS: RESULTS OF A 24-WEEK MULTICENTER, RANDOMIZED, DOUBLEBLIND, PLACEBO-CONTROLLED TRIAL

pemvidutide (ALT-801) - Altimmune

Stephen A. Harrison1; Shaheen Tomah2; John J Suschak2; Jonathan Kasper2; M. Scot Roberts2; M Scott Harris2; Sarah K Browne2

Nov 11, 2023